Drug Regulatory Authority of Pakistan (DRAP)

Case Summary

DRAP identified barriers to pharmaceutical export, including non-compliance with cGMP and lack of research and development.

Source

Title

Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry.

Type

academic paper

Year

2024

Confidence Score

80%